Codexis (CDXS) director David V. Smith granted 66,350 stock options at $2.48

Rhea-AI Filing Summary

CODEXIS, INC. director David V. Smith received a grant of stock options covering 66,350 shares of common stock. The options have an exercise price of $2.48 per share and expire on June 17, 2036.

According to the footnote, the award vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, as long as Smith continues serving as a director through that vesting date. After this grant, his reported option holdings from this award total 66,350 shares.

Insights

Equity compensation analyst

Director receives routine stock option grant as equity compensation.

Director David V. Smith was granted options for 66,350 shares of CODEXIS, INC. common stock at an exercise price of $2.48 per share, expiring on June 17, 2036. The transaction is coded as a grant/award, not an open‑market trade.

The award vests in a single tranche on the earlier of the first anniversary of the grant or the next annual stockholder meeting, contingent on continued board service. This structure is typical for non‑employee director compensation and does not, by itself, signal a change in sentiment about the stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Smith David V

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	66,350	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 66,350 shares (Direct)

Footnotes (1)

1. F1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

Key Figures

Option grant size: 66,350 shares Exercise price: $2.48 per share Expiration date: June 17, 2036 +2 more

5 metrics

Option grant size 66,350 shares Stock Option (Right to Buy) granted to director

Exercise price $2.48 per share Conversion or exercise price of stock options

Expiration date June 17, 2036 Option term end date

Underlying shares 66,350 shares Common stock underlying the options

Post-grant option holdings from award 66,350 shares Total shares following transaction for this option grant

Key Terms

Stock Option (Right to Buy), exercise price, vests and becomes exercisable, annual stockholder meeting

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "2.4800""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests and becomes exercisable financial

"This option vests and becomes exercisable with respect to all of the shares"

annual stockholder meeting financial

"on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/18/2026 - 04:55 PM Accepted by SEC EDGAR 06/18/2026 - 04:55 PM Learn about SEC filing dates

FAQ

What did CODEXIS (CDXS) director David V. Smith report on this Form 4?

David V. Smith reported receiving a stock option grant for 66,350 shares of CODEXIS common stock. The options were awarded as equity compensation and are not a market purchase or sale, but a grant from the company under its compensation arrangements.

What is the exercise price and term of David V. Smith’s new CODEXIS options?

The stock options granted to David V. Smith have an exercise price of $2.48 per share and expire on June 17, 2036. This defines the price he must pay to buy shares and the final date he can exercise the options.

How many CODEXIS shares are covered by David V. Smith’s new stock option grant?

The grant covers options on 66,350 shares of CODEXIS common stock. After the transaction, his holdings for this specific award total 66,350 option shares, reflecting the full size of the reported equity compensation grant in this filing.

When do David V. Smith’s CODEXIS stock options vest according to the filing?

The options vest and become exercisable for all 66,350 shares on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, provided he continues serving as a director through that vesting date as described in the footnote.

Does this CODEXIS Form 4 show a stock purchase or sale by David V. Smith?

The Form 4 shows a grant of stock options, not an open‑market purchase or sale. It is coded as an acquisition by grant or award, indicating routine director compensation rather than discretionary trading in CODEXIS shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith David V

(Last) (First) (Middle)

C/O CODEXIS, INC.

200 PENOBSCOT DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.48	06/17/2026		A		66,350		(1)	06/17/2036	Common Stock	66,350	$0	66,350	D

Explanation of Responses:

1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

	/s/ Georgia Erbez, as Attorney-in-Fact for David V. Smith	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)